FUNGAL PNEUMONIA WITH REVIEW OF LITERATURE ON 2 CANDIDA – A SILENT KILLER IN CRITICAL CARE 3 PATIENTS

Abstract

Pulmonary fungal infection appears to be an important problem in patients with respiratory diseases especially in patients who are admitted to the medical respiratory ICU.  Several host characteristics, such as a very high incidence of pulmonary tuberculosis (PTB) 
 malignancies, chronic pulmonary obstructive disease (COPD) [2], and others, also contribute to a high predilection for fungal diseases in the Indian population. Many outbreaks of different fungal infections have been periodically reported from different parts of India, including Candida auris  and, more recently, COVID-19-associated mucormycosis  Fungal infections are neglected most of the time, may be due to our less resources to diagnose or  we are from a country with maximum TB burden. Most of the time we start the patients on Anti  tubercular drugs based on clinic-radiological basis without investigating the patients to rule out fungal infections but fungal infections must to be ruled out as many articles supports that fungal  infections are a silent killer in many long standing bacterial infections as a super added infections or a new infection in a immunosuppresed patients.